July 14, 2026 Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) today announced that its Board of Directors has elected...
July 9, 2026 C-Path Awards $250,000 Grant to Advance New Treatment for Sepsis-Associated Neurocognitive Dysfunction TUCSON, Ariz., July 9, 2026 — Critical Path Institute® (C-Path) has awarded a $250,000 research grant to Teresa Sanchez, Ph.D.,
July 9, 2026 Wendy Ruyle Learned That Groundbreaking Science Alone Is Not Enough Early in her career, Wendy Ruyle worked as a study coordinator on clinical trials, a role that put her in direct contact with...
July 3, 2026 Many Conferences Lack Clear Information about Disability Access The logistics and structural barriers of many research conferences prevent full participation of people with disabilities.
June 30, 2026 Katrina Peron Went From Artificial Hearts to Advancing Regulatory Science The SynCardia Total Artificial Heart is exactly what it sounds like: a mechanical pump that takes over for a failing human heart..
June 29, 2026 C-Path’s Disease Modeling Coalition to Convene Scientific Workshop on Pediatric Evidence Generation in Paris Critical Path Institute® (C-Path) is pleased to announce that its Disease Modeling Coalition will host a two-day
June 23, 2026 Connecting the Dots: Advancing Drug Development on a Global Scale This latest C-Path podcast episode centers on the global strategy and impact of C-Path’s regulatory science efforts...
June 15, 2026 C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes TUCSON, Ariz., June 15, 2026 — Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today...
June 11, 2026 C-Path Appoints Biotech Executive and Investor Dr. Milad Alucozai to Board of Directors TUCSON, Ariz., June 11, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Milad Alucozai...
June 10, 2026 C-Path Appoints Biotechnology Leader and Veteran Life-Science Attorney Yalonda Howze to Board of Directors TUCSON, Ariz., June 10, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Yalonda Howze...